Thus, it can be argued that the AET induced UPR activation in diseases as CKD, which already have a baseline elevation in markers related to UPR (GRP78 and ATF4 mRNA levels and GRP78 protein levels), do not attenuate but amplify the UPR in skeletal muscle 7. This evidence concerns the gene ATF4 and chronic kidney disease.